Health Care Providers’ Experiences With and Perceived Barriers to Implementation of Long-Acting Injectable HIV Preexposure Prophylaxis: A Cross-Sectional Survey

Elena Beideck, Ryan Gould, Douglas Krakower, Division of Infectious Diseases, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, The Fenway Institute, Fenway Health, Department of Population Medicine, Harvard Medical School

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Published online on July 22, 2026

Abstract

Journal of the International Association of Providers of AIDS Care (JIAPAC), Volume 25, January-December 2026.
IntroductionLong-acting injectable cabotegravir (CAB-LA) is highly efficacious as PrEP and could increase PrEP coverage, though uptake has been limited.MethodsWe surveyed healthcare professionals regarding experiences with CAB-LA implementation in the ...